MedPath

修正药业集团天汉药业有限公司

Ownership
-
Established
2022-06-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

150

NMPA:150

Drug Approvals

Montmorillonite powder

Product Name
蒙脱石散
Approval Number
国药准字H20193103
Approval Date
Apr 18, 2024
NMPA

肾炎安胶囊

Approval Number
国药准字Z20083275
Approval Date
Oct 19, 2023
NMPA

Famotidine, Calcium Carbonate and Magnesium Hydroxide Chewable Tablets

Product Name
法莫替丁钙镁咀嚼片
Approval Number
国药准字H20080686
Approval Date
Oct 10, 2023
NMPA

生脉饮

Approval Number
国药准字Z20184051
Approval Date
Jul 25, 2023
NMPA

Levofloxacin Hydrochloride Tablets

Product Name
盐酸左氧氟沙星片
Approval Number
国药准字H20083676
Approval Date
Mar 15, 2023
NMPA

Azithromycin Tablets

Product Name
阿奇霉素片
Approval Number
国药准字H20083435
Approval Date
Mar 15, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20083681
Approval Date
Nov 7, 2022
NMPA

抗骨增生片

Approval Number
国药准字Z20063829
Approval Date
Apr 20, 2021
NMPA

咽炎片

Approval Number
国药准字Z20093677
Approval Date
Nov 16, 2020
NMPA

感冒退热颗粒

Approval Number
国药准字Z20063608
Approval Date
Nov 16, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.